News and Comments

INCYTE: SHOWS ITS PATH TOWARDS GROWTH

  Wednesday, February 12, 2014

 More...

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

Dendreon (DNDN) Velcade (bortezomib) Sangamo (SGMO) ImmunoGen (IMGN) Sanofi (SNY) Agenus (AGEN) NEKTAR (NKTR)) Theravance Bio Pharma (TBPH) Illumina (ILMN) ABBVIE (ABBV) Seattle Genetics (SGEN) INNOVIVA (INVA) JUNO (JUNO) AGOS (ARGS) Multiple Myeloma Trastuzumab-DM1 BIOMARIN (BMRN) CompuGen (CGEN) ADVENTRIX (ANX) SUNESIS PHARMACEUTICALS (SNSS) Intercept (ICPT) SERES THERAPEUTICS (MCRB) Ariad (ARIA) AstraZeneca (AZN) Herceptin ARCA (ABIO) galapagos (GLPG) Sarepta (SRPT) Anadys (ANDS) Aimmune Therapeutics (AIMT) Array Pharmaceuticals (ARRY) IDERA (IDRA) Exelixis (EXEL) Telaprevir Prolor Biotech (PBTH) Incyte (INCY) Biogen Idec (BIIB) Roche (ROCHE) Global Cell Therapeutics (GBT) Alnylam (ALNY) Mirati Therapeutics (MRTX) NOVOCURE (NVCR) Micromet (MITI) Merck (MRK) Prosensa (RNA) Spike Therapeutics (ONCE) Revlimid (lenolidamide) Bristol-Myers Squibb (BMY) OSI (OSIP) Anacor (ANAC) Vitae Pharmaceuticals (VTAE) PORTOLA (PTLA) Cytokinetics (CYTK) Xoma (XOMA) Inovio (INO) Intermune (ITMN) CEMPRA (CEMP) ZALTRAP™ Theravance (THRX) Sanofi (SNA) Human Longevity (HLI) MODERNA Ocular Therapeutix (OCUL) Vertex (VRTX) ISIS (ISIS) GlaxoSmithKline (GSK) Regeneron (REGN) Intrexon (XON) NANTKWEST (NK) Ionis (IONS) Idenix (IDIX) Advaxis (ADXS) GUARDIAN HEALTH Sanofi-Aventis (SAN) Valeant Pharmaceuticals International (VRX) KERYX (KERX) Elan (ELN) Sequenom (SQNM) ACADIA (ACAD) Zerenex Biocryst (BCRX) ARGOS (ARGS) Roche (RHHBY) Genentech Rapamune Bellicum (BLCM) PTC Therapeutics (PTCT) CRISPR Therapeutics (CRSP) Agenus (AGEN Gilead (GILD) Editas (EDIT) Ziofpharm (ZIOP) Pluristem (PSTI) Auspex (ASPX) Onyx (ONXX) SYNTA (SNTA) Abbott Laboratories (ABT) Galena (GALE) Alder Biopharmaceuticals (ALDR) Dynavax (DVAX) Human Genome Sciences (HGSI) TOKAI (TKAOI) Endometrial Cancer Jazz Pharmaceuticals (JAZZ) AERIE PHARMACEUTICALS REGULUS (RGLS) HALOZYME (HALO) Benlysta (belimumab) Ridaforolimus Adaptimmune (ADAP) Tysabri C4 Therapeutics VANDA (VNDA) Amgen (AMGN) RenenxBio (RGNX) KITE (KITE)